Validation of Apnea LinkTM for Sleep Apnea Syndrome Screening in a Bariatric Population
Overview
Sleep apnea syndrome (OSA) frequently occurs in obese population undergoing bariatric surgery. There is a need for alternative screening tools for sleep apnea detection in the pre-operative period. The investigators would like to compare ApneaLink and complete polysomnography in this population.
Full Title of Study: “Validation of Apnea LinkTM (ResMed Corporation, Poway, California) for Sleep Apnea Syndrome Screening in a Bariatric Population”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: May 2011
Detailed Description
OSA can occur in up to 78% of patients undergoing bariatric surgery(1). Moderate to severe case will benefit from CPAP therapy, that can help avoiding post-operative complications(2). In this population, the investigators propose complete attended in-hospital polysomnography (PSG)in patients with a clinical high probability of OSA. According to obesity epidemics (3), waiting list for PSG in sleep labs is every day longer. The investigators want to assess sensitivity and specificity of a new portable screening tool, ApneaLink, to detect OSA in a bariatric population. Design: monocentric and prospective study Methods: Patients: – OSA suspicion based on : – symptoms and signs (snoring, apneas , neck circumference >38 (women) or 43cm (men)) – BMI > 50 – BMI > 40, > 40 y – BMI > 35, men, hypertension – increased serum Bicarbonate – Polyglobulia Measurements – Polysomnography in sleep lab with concommitant recording performed with Apnea LinkTM (nasal flow and oxymétry recording). – between 2 weeks : recording performed with Apnea LinkTM (nasal flow and oxymétry recording)at home.
Arms, Groups and Cohorts
- bariatric population
- obese patients in whom a bariatric surgery is planified
Clinical Trial Outcome Measures
Primary Measures
- Number of patients with correct diagnosis of OSA with ApneaLink. Therefore, we will compare apnea-hypopnea index measured with ApneaLink with apnea-hypopnea index measured during polysomnography.
- Time Frame: 2 weeks
Participating in This Clinical Trial
Inclusion Criteria
- obese patients – > 18 years old – in whom a bariatric surgery is planified and who have to undergo a polysomnography for OSA screening Exclusion Criteria:
- pulmonary, neurologic, neuromuscular disease – < 18 years old
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Centre Hospitalier Universitaire Saint Pierre
- Provider of Information About this Clinical Study
- Principal Investigator: Marie Bruyneel, Chef de Clinique – Centre Hospitalier Universitaire Saint Pierre
- Overall Official(s)
- Marie Bruyneel, MD, Principal Investigator, CHU St Pierre
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.